astragaloside a has been researched along with Cognitive Decline in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 5 (71.43) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, SS; Feng, L; Han, CJ; Liu, JP; Shi, LL; Shi, Y; Wang, B; Wang, X; Zhang, RH; Zhang, YH | 1 |
| Chen, T; Ma, J; Wang, R | 1 |
| Li, X; Liu, J; Niu, Y; Yu, C; Zhang, J | 1 |
| Abd Elkader, HAE; Abdou, HM; Essawy, AE; Khamiss, OA | 1 |
| Chen, F; Cheng, XY; Li, J; Liu, HT; Wang, R; Yang, D; Yang, H; Yang, XH; Yao, Y; Zheng, P | 1 |
| Jia, XT; Pan, YF; Peng, XZ; Song, EF | 1 |
| Deng, X; Fang, F; Li, H; Li, M; Ma, S | 1 |
7 other study(ies) available for astragaloside a and Cognitive Decline
| Article | Year |
|---|---|
Astragaloside IV-mediated inhibition of oxidative stress by upregulation of ghrelin in type 2 diabetes-induced cognitive impairment.
Topics: AMP-Activated Protein Kinases; Animals; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Ghrelin; Insulin Resistance; Oxidative Stress; Rats; Superoxide Dismutase-1; Up-Regulation | 2023 |
Astragaloside IV ameliorates cognitive impairment and protects oligodendrocytes from antioxidative stress via regulation of the SIRT1/Nrf2 signaling pathway.
Topics: Cognitive Dysfunction; Dementia, Vascular; Humans; NF-E2-Related Factor 2; Oligodendroglia; Oxidative Stress; Signal Transduction; Sirtuin 1 | 2023 |
Astragaloside IV-induced Nrf2 nuclear translocation ameliorates lead-related cognitive impairments in mice.
Topics: Animals; Antioxidants; Cognitive Dysfunction; Glycogen Synthase Kinase 3 beta; Heme Oxygenase-1; Membrane Proteins; Mice; NF-E2-Related Factor 2; Organometallic Compounds; Oxidative Stress; PC12 Cells; Phosphorylation; Rats; Reactive Oxygen Species; Saponins; Signal Transduction; Triterpenes | 2021 |
Anti-anxiety and antidepressant-like effects of astragaloside IV and saponins extracted from Astragalus spinosus against the bisphenol A-induced motor and cognitive impairments in a postnatal rat model of schizophrenia.
Topics: Animals; Antidepressive Agents; Benzhydryl Compounds; Cognitive Dysfunction; Male; Phenols; Rats; Rats, Sprague-Dawley; Saponins; Schizophrenia; Triterpenes | 2021 |
Astragaloside IV Ameliorates Cognitive Impairment and Neuroinflammation in an Oligomeric Aβ Induced Alzheimer's Disease Mouse Model via Inhibition of Microglial Activation and NADPH Oxidase Expression.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Astragalus Plant; Cognitive Dysfunction; Cytokines; Disease Models, Animal; Drugs, Chinese Herbal; Hippocampus; Male; Maze Learning; Mice, Inbred ICR; Microglia; NADP; NADPH Oxidases; Neuroinflammatory Diseases; Neurons; Neuroprotective Agents; Phytotherapy; Reactive Oxygen Species; Saponins; Triterpenes | 2021 |
Astragaloside Ⅳ Protects Against Aβ1-42-induced Oxidative Stress, Neuroinflammation and Cognitive Impairment in Rats.
Topics: Animals; Catalase; Cognitive Dysfunction; Interleukin-1beta; Male; Maze Learning; Memory; Memory Disorders; Oxidative Stress; Rats; Rats, Sprague-Dawley; Saponins; Spatial Learning; Superoxide Dismutase; Triterpenes; Tumor Necrosis Factor-alpha | 2018 |
Astragaloside IV attenuates cognitive impairments induced by transient cerebral ischemia and reperfusion in mice via anti-inflammatory mechanisms.
Topics: Animals; Anti-Inflammatory Agents; Cognitive Dysfunction; Disease Models, Animal; Inflammation; Ischemic Attack, Transient; Male; Mice; Neuroprotective Agents; NF-kappa B; Reperfusion; Saponins; Toll-Like Receptor 4; Triterpenes | 2017 |